Choledocholithiasis with Drs. David Vitale & Lucas Neff

Published:
Choledocholithiasis with Drs. David Vitale & Lucas Neff podcast cover art
3 Views
0 Likes
0 Shares
0 Comments

StayCurrentMD

View profile →

Inside this episode

Kai, the Library's AI content creator, listened to this episode and mapped who's speaking, the chapters, key claims, and cases. Every item links to the exact moment in the recording.

AI-enriched

Who's speaking

  • Cecilia Gigena — host
  • David Vitale — guest
  • Luke Neff — guest
  • Speaker 4

Chapters

  • 0:00Introduction and Risk Stratification — Introduction of speakers and discussion of choledocholithiasis risk factors, including metabolic diseases, hemolysis, and biliary anomalies. Presentation of a case of a 14-year-old with right upper quadrant pain and discussion of ASGE risk stratification guidelines.
  • 2:38Pediatric Predictors and Treatment Approaches — Discussion of pediatric-specific predictors for common bile duct stones, including the pediatric duct score. Comparison of ERCP versus laparoscopic common bile duct exploration, with emphasis on institutional expertise and resource availability.
  • 5:17Surgery-First Paradigm — Dr. Neff presents a surgery-first approach using intraoperative cholangiogram (IOC) to avoid longer hospital stays and reduce resource utilization. Discussion of techniques for laparoscopic stone removal, including flushing stones forward into the duodenum and ampullary dilation.
  • 9:37Technical Details of Laparoscopic CBD Exploration — Detailed description of equipment and technique for laparoscopic common bile duct exploration, including use of ureteral stents, guide wires, and angioplasty balloons. Discussion of balloon sizing, dilation technique, and when to abort the procedure.
  • 13:47Learning Curve and Summary — Discussion of the learning curve (5-10 cases) for laparoscopic common bile duct exploration and summary of key diagnostic and treatment principles.

Key claims

  • 1:03Choledocholithiasis is more common in older children, children with higher BMI, and patients of Hispanic ethnicity — David Vitale
  • 0:55Risk factors for choledocholithiasis include metabolic diseases, hemolysis such as sickle cell, and congenital biliary anomalies like choledochal cysts — David Vitale
  • 1:52According to ASGE guidelines, patients with high probability of common bile duct stones (common bile duct stones seen on ultrasound, ascending cholangitis, or quite high bilirubin) should go straight to ERCP — David Vitale
  • 2:11Patients with intermediate risk (abnormal liver biochemical tests or dilated common bile ducts) can undergo endoscopic ultrasound, MRCP, laparoscopic cholangiogram, or intraoperative ultrasound — Cecilia Gigena
  • 2:40In pediatric patients, direct bilirubin or conjugated bilirubin more than 2 was the most predictive factor for common bile duct stones — David Vitale
  • 2:50Common bile duct diameter greater than 6 millimeters was most sensitive for predicting common bile duct stones in children, although without statistical significance — Cecilia Gigena
  • 3:03The pediatric duct score (published in Journal of American College of Surgeons with 10 centers) found that ducts greater than 6 millimeters, common bile duct stones on ultrasound, or total bilirubin greater than 1.8 were the most predictive risk factors — David Vitale
  • 3:41Pediatric literature with small sample size shows that doing same anesthesia laparoscopic cholecystectomy with ERCP in stone disease led to less anesthesia time and lower length of stay — David Vitale
  • 4:03Retrospective data comparing ERCP versus laparoscopic common bile duct exploration is conflicted and the choice is probably institution and provider dependent based on expertise — David Vitale
  • 4:18Randomized trials from 2013 show no significant difference in morbidity, mortality, retained stones, or failure rates between ERCP and laparoscopic common bile duct exploration — Cecilia Gigena
  • 4:39Stones above the cystic duct pose a problem because they can float up during attempted laparoscopic removal, making the procedure more difficult — David Vitale
  • 5:00Local expertise and availability is probably the most important factor in deciding between ERCP and laparoscopic common bile duct exploration — David Vitale
  • 9:12Most free-standing children's hospitals do not have ERCP capabilities — Cecilia Gigena
  • 6:42The mantra for laparoscopic common bile duct exploration is all stones go forward, using balloons to dilate the sphincter and flush stones antegrade into the duodenum — Luke Neff
  • 7:30If you're having to open up the common bile duct to extract the stone and you had ERCP capability, that's probably not the right thing to do in most cases — Luke Neff
  • 9:37A 12 gauge angiocath is used for laparoscopic common bile duct exploration, with a new incision made to achieve a flat angle of entry into the cystic ductotomy — Luke Neff
  • 9:57A 6 French ureteral stent cut down shorter for better flow is used with a glide wire, employing a cylinder technique to navigate the valves — Luke Neff
  • 10:37An angioplasty balloon of 6 or 8 millimeters (but definitely not more than that) is used to dilate the sphincter — Luke Neff
  • 11:02The balloon is inflated in the duct and pulled back to provide tactile feedback to locate the sphincter, then partially deflated to straddle the ampulla, then inflated to full profile under fluoroscopy and held for about 5 minutes — Luke Neff
  • 11:23Never use a balloon larger than the dilated common bile duct because literature shows a higher rate of pancreatitis with ampullary dilation without sphincterotomy — David Vitale
  • 12:24If the pancreatic duct is seen on fluoroscopy during the procedure, stop because that has a higher risk for pancreatitis — Cecilia Gigena
  • 12:34The prevalence of stone disease is increasing — Luke Neff
  • 13:40The learning curve for laparoscopic common bile duct exploration is around 5 to 10 cases, though this is person-specific — Luke Neff
  • 13:24The position of the 12-gauge angiocath is really important, and the ability to manipulate the catheter and wire in the duct depends on the initial setup and how flat the angle of entry is into the cystic duct — Luke Neff

Cases discussed

  • 1:1714-year-old female with choledocholithiasis

Open questions

  • What is the optimal balloon size for ampullary dilation in pediatric patients of different ages and common bile duct diameters?
  • How can centers without pediatric ERCP capabilities develop competency in laparoscopic common bile duct exploration?
  • What are the long-term outcomes comparing ERCP versus laparoscopic exploration in pediatric choledocholithiasis?
This episode was analyzed and enriched by Kai, the Library's AI content creator. Every item links to the moment it comes from — click a timestamp to listen in context.
Written for:

Choledocholithiasis in an Adolescent: Choosing Between ERCP and Laparoscopic Exploration

The patient case from this episode, retold from presentation to outcome with the decisions made along the way. Written by Kai from the episode transcript and reviewed before publishing.

For the care team · Case narrative · AI-written, human-reviewed

The Presentation

A 14-year-old female presented with right upper quadrant pain and tenderness on examination [case1]. Laboratory studies showed elevated transaminases with a total bilirubin of 1.8 and direct bilirubin of 1.3 [case1]. Her BMI fell in the 98th percentile [case1]. Abdominal ultrasound demonstrated gallstones and a common bile duct measuring 5 millimeters, though the distal duct could not be visualized [case1].

The clinical picture suggested choledocholithiasis — a stone lodged in the common bile duct. The patient fit the epidemiological profile: older child, elevated BMI, Hispanic ethnicity 1:03. But the imaging was incomplete, and the biochemical abnormalities placed her in the intermediate-risk category rather than the high-risk group that would mandate immediate ERCP [c3, c4].

The Decision Point

Intermediate-risk patients — those with abnormal liver biochemistry or dilated ducts but without stones visualized on ultrasound, ascending cholangitis, or markedly elevated bilirubin — can be evaluated with endoscopic ultrasound, MRCP, laparoscopic cholangiogram, or intraoperative ultrasound 2:11. The ASGE guidelines offer this menu of options, but they do not specify which to choose [c3, c4].

In pediatric patients, direct bilirubin greater than 2 is the most predictive factor for common bile duct stones 2:40. Common bile duct diameter greater than 6 millimeters was the most sensitive predictor, though without statistical significance 2:50. A multi-center pediatric duct score identified three high-yield criteria: duct diameter greater than 6 millimeters, stones visible on ultrasound, or total bilirubin greater than 1.8 3:03. This patient had one of three — the bilirubin threshold — placing her in the intermediate probability range.

The team obtained an MRCP, which confirmed a stone in the common bile duct [case1]. Now the question became not whether to intervene, but how. The patient could undergo ERCP followed by laparoscopic cholecystectomy, or the surgeon could attempt laparoscopic common bile duct exploration at the time of cholecystectomy. Pediatric data, though limited in sample size, suggest that same-anesthesia ERCP with cholecystectomy reduces total anesthesia time and length of stay compared to staged procedures 3:41.

But what about ERCP versus laparoscopic exploration as the primary approach? Retrospective data comparing the two are conflicted, and the choice is likely institution- and provider-dependent based on local expertise 4:03. Randomized trials from 2013 show no significant difference in morbidity, mortality, retained stones, or failure rates between the two techniques 4:18. "I really think again it gets back to institution dependent expertise and it's probably provider dependent and the institution's experience with this" [q2].

What the Team Did

The patient underwent ERCP followed by laparoscopic cholecystectomy [case1]. The choice reflected the resources available at this institution — most free-standing children's hospitals do not have ERCP capabilities 9:12, but this center did. Local expertise and availability is likely the most important factor in the decision tree 5:00.

Had ERCP not been available, laparoscopic common bile duct exploration would have been a reasonable alternative. The technique involves passing a 12-gauge angiocath through a new incision positioned to achieve a flat angle of entry into the cystic duct 9:37. A 6 French ureteral stent, cut shorter for better flow, is advanced over a glide wire using a cylinder technique to navigate the valves of Heister 9:57. The mantra is "all stones go forward" [q4] — balloons dilate the sphincter, and stones are flushed antegrade into the duodenum 6:42.

The balloon technique requires precision. An angioplasty balloon of 6 or 8 millimeters — but definitely not larger — is used 10:37. The balloon is inflated in the duct and pulled back to provide tactile feedback locating the sphincter, then partially deflated to straddle the ampulla, then inflated to full profile under fluoroscopy and held for approximately 5 minutes 11:02. The balloon must never exceed the diameter of the dilated common bile duct, as literature shows a higher rate of pancreatitis with ampullary dilation without sphincterotomy 11:23. If the pancreatic duct becomes visible on fluoroscopy, the procedure should be stopped due to increased pancreatitis risk 12:24.

If laparoscopic exploration requires opening the common bile duct to extract the stone and ERCP capability exists, "that's probably in most cases, not the right thing to do" [q5]. Stones above the cystic duct pose particular difficulty because they can float proximally during attempted laparoscopic removal 4:39.

What This Case Changes

The outcome of this patient's treatment was not discussed [case1]. But the case illustrates the central tension in managing pediatric choledocholithiasis: equivalent outcomes can be achieved through different technical approaches, and the right choice depends less on abstract superiority than on what your institution can deliver reliably.

For centers without pediatric ERCP, laparoscopic common bile duct exploration is a learnable skill with a curve of approximately 5 to 10 cases 13:40. The critical technical factor is the position of the initial angiocath — the ability to manipulate catheter and wire depends entirely on achieving a flat angle of entry into the cystic duct 13:24. For centers with ERCP, same-anesthesia combined procedures minimize total anesthesia exposure and hospital stay 3:41.

The prevalence of stone disease is increasing 12:34. Surgeons should be comfortable with options beyond reflexive MRCP followed by ERCP, particularly when resources or expertise make that pathway inefficient or unavailable.

Takeaways from this story

  • In pediatric choledocholithiasis, direct bilirubin >2 is most predictive; duct diameter >6mm and total bilirubin >1.8 add risk.
  • ERCP and laparoscopic CBD exploration have equivalent outcomes; choose based on local expertise and ERCP availability.
  • For laparoscopic exploration, use 6-8mm balloons smaller than the dilated duct; never exceed duct diameter to avoid pancreatitis.
  • Same-anesthesia ERCP with cholecystectomy reduces total anesthesia time and length of stay versus staged procedures.
  • Flat angle of entry into cystic duct is critical for laparoscopic CBD exploration; learning curve is 5-10 cases.

Topic overview

This discussion covers the diagnosis and management of choledocholithiasis (common bile duct stones) in pediatric patients. The speakers compare two treatment approaches: ERCP (endoscopic retrograde cholangiopancreatography) versus laparoscopic common bile duct exploration. Key clinical predictors for common bile duct stones in children include direct bilirubin greater than 2 mg/dL, common bile duct diameter greater than 6 millimeters, and total bilirubin greater than 1.8 mg/dL. The discussion emphasizes that both ERCP and laparoscopic exploration have similar outcomes in expert hands, but resource availability and institutional expertise should guide the choice of approach.

Key takeaways

  • Direct bilirubin >2 mg/dL and CBD diameter >6mm are most predictive of choledocholithiasis in children requiring intervention.
  • Same-anesthesia ERCP with laparoscopic cholecystectomy reduces total anesthesia time and hospital length of stay versus staged procedures.
  • Intraoperative cholangiogram allows real-time decision-making: negative IOC permits immediate discharge; positive IOC guides CBD exploration or ERCP.
  • Local expertise availability should drive treatment approach—ERCP versus laparoscopic CBD exploration show equivalent outcomes in retrospective data.
  • Stones above the cystic duct junction pose technical challenges for laparoscopic removal and may require endoscopic intervention.

Keywords

Hashtags

Transcript

Click "Show Transcript" to view the full text (15128 characters)

Comments

Loading comments...